Dawen Zhao

8PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational imagingMolecular targetsTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 08, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

|Dec 05, 2025
Dynamic Contrast-enhanced MRI for Evaluating Breast Cancer Chemotherapy Response Using Conditional Generative Adversarial Networks.

Chad A Arledge, Alan H Zhao, Umit Topaloglu

|Sep 14, 2024
Exposed Phosphatidylserine as a Biomarker for Clear Identification of Breast Cancer Brain Metastases in Mouse Models.

Lulu Wang, Alan H Zhao, Chad A Arledge

|Sep 09, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.

Margaret R Smith, Caroline B Dixon, Yuezhu Wang

|Aug 01, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.

Gao Guo, Ke Gong, Nicole Beckley

|Mar 17, 2022
A novel nano-immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single-cell RNA-sequencing.

Yang Liu, Dawen Zhao

Pageof 2

Frequent Collaborators

3 joint publications

Sandeep Burma

3 joint publications

Amyn A Habib

2 joint publications

Chad A Arledge

2 joint publications

Fei Xing